[Articles] An immunogenomic classification of solid tumours reveals subtype-specific therapeutic vulnerabilities for immunotherapy

Leveraging clinical feasible RNA-seq and TMB analysis, our model exhibits robust predictive efficacy of ICB response in multiple cancers, enabling subtype-tailored therapeutic combinations to improve immunotherapy response.